logo
I've been CURED of the deadliest form of brain cancer after being told I had months to live – I'm still here years later

I've been CURED of the deadliest form of brain cancer after being told I had months to live – I'm still here years later

The Sun3 days ago
A DAD given months to live after being diagnosed with the deadliest form of brain cancer saw his disease vanish - and his scans are still clear years later.
Most people with glioblastoma, an aggressive and fast growing type of brain tumour, don't live past 12 to 18 months.
6
6
The Wanted's Tom Parker died from the disease in March 2022.
Ben Trotman was diagnosed with glioblastoma in October 2022 at the age of 40, and brought his wedding forward after doctors said he'd likely live less than a year.
But he was cleared of cancer after being given a new drug called ipilimumab, as part of a breakthrough trial.
Well over two years later, Ben continues to show no signs of glioblastoma and his scans remain clear.
The now 43-year-old became a dad during that time is "focused on rebuilding the life he thought he had lost".
Now, the NHS has launched a new immunotherapy trial to treat the deadly brain cancer is seeking patients to take part in it.
The study - set up in memory of Baroness Margaret McDonagh, who died of the disease - will recruit 16 people over an 18-month period.
People diagnosed with glioblastoma will receive ipilimumab with immunotherapy, a type of cancer treatment that uses the immune system combat cancer cells.
They'll then undergo current standard treatment - which includes radiotherapy, chemotherapy and surgery - while their immune system is at its strongest.
The trial, ran by University College London Hospital's National Hospital for Neurology and Neurosurgery, follows a previous one for the same drug which closed due to lack of recruitment.
Man, 64, plays guitar while having a brain tumour
Consultant medical oncologist, Dr Paul Mulholland, who is leading the new trial and treated Ben said: "It is very unusual to have a clear scan with glioblastoma, especially when [Ben] didn't have the follow-up surgery that had been planned to remove all of the tumour that was initially visible on scans.
"We hope that the immunotherapy and follow-up treatment Ben has had will hold his tumour at bay - and it has so far, which we are delighted to see."
Ben got married to Emily two months after the immunotherapy treatment and in April, his daughter Mabel was born.
Emily said: "Getting this diagnosis was the most traumatic experience.
6
6
"We were grappling with the fact that Ben had gone from being apparently perfectly healthy to having months to live.
"Had we not met Dr Mulholland, that would have been it for us. We felt we had a lucky break in an otherwise devastating situation."
Ben went on to have the current standard treatment of radiotherapy and chemotherapy.
He has quarterly scans, which continue to be clear.
What are the symptoms of glioblastoma and how soon do they show?
Glioblastomas are the most common brain tumour in adults, while also being very aggressive and deadly.
Brain Tumour Research says tumours increase pressure in the skull, causing headaches.
Symptoms to look for are:
Headaches
Loss of appetite
Nausea and vomiting
Loss of balance
Mood swings
Problems speaking
Problems with memory or concentration
Seizures
Impaired vision
The symptoms can initially be quite non-specific, meaning they could be mistaken for lots of other conditions- even stress or a hangover.
The brain controls so many different functions that symptoms can vary greatly depending on where in the brain the tumour is.
Glioblastomas are very fast growing. Once found, experts can see them double within seven weeks.
But, according to Dr Stephen Bagley, assistant professor of medicine at Penn Medicine, the first spark of glioblastoma in the brain remains something of a mystery to medical experts.
One study concluded that a glioblastoma starts growing 330 days on average - almost a year - before a diagnosis.
Another found that there are changes in immune function up to five years before a diagnosis, with markers in blood samples - but symptoms only occur three months prior.
The dad said: "We obviously don't know what the future holds but having had the immunotherapy treatment and getting these encouraging scan results has given Emily and I a bit of hope.
"We are focused on rebuilding the life we thought we had lost and enjoying being parents."
Dame Siobhain McDonagh MP led a fundraising campaign to raise more than £1 million to cover the costs of the new trial.
6
6
Her sister, Baroness McDonagh, died from glioblastoma in 2023.
Dame Siobhain said: "My beloved sister Margaret was appalled to discover that there had been no advances in brain cancer treatment for decades when she was diagnosed with glioblastoma.
"Changing this was Margaret's final campaign and one that I have continued in her memory.
"I am so grateful to the many people who knew and respected Margaret who have come together and helped to raise funds and campaign for this new trial that we are calling Margaret's Trial."
Dr Mulholland said: "When I met Margaret she said to me 'what can I do to support you to cure this disease?'.
"I am incredibly grateful to her and to Siobhain whose campaigning and fundraising in her sister's memory has led to this new clinical trial opening for patients with this most aggressive form of brain cancer that has such a poor prognosis, with most patients surviving just nine months after diagnosis.
"The crucial element of this trial is that patients will have their immune system boosted by the drug before they have any other treatment, when they are fit and well enough to tolerate the immunotherapy.
"We're taking everything we have learned from previous trials into this new study and we are already planning follow-on trials.
"My aim is to find a cure for glioblastoma."
The National Brain Appeal is currently funding two posts in support of Dr Mulholland's research.
Treatment will take place at the NIHR UCLH's Clinical Research Facility and at the National Hospital for Neurology and Neurosurgery.
Patients interested in the new Win-Glio trial should discuss it with their consultant.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Suffolk care provider rated as inadequate by watchdog
Suffolk care provider rated as inadequate by watchdog

BBC News

time11 minutes ago

  • BBC News

Suffolk care provider rated as inadequate by watchdog

A care provider that looks after people with dementia, mental health conditions and physical disabilities has been rated inadequate by a health watchdog. Hearts of Care Agency, based in Ipswich, Suffolk, was placed into special measures by the Care Quality Commission (CQC).The CQC said the firm, which provides cares for 16 people in their own home, was inadequate for being safe, effective, responsive and well-led. Hearts of Care Agency said it was "disappointed" by the CQC's rating but would "learn from our mistakes". The firm being placed in special measures means the business will be closely monitored and a timeframe has been set out for improvements to be made, the CQC said. A report, which was published by the watchdog, stated that a condition was placed on Hearts of Care Agency when it registered with the CQC to not provide services for autistic adults or adults with a learning however, found that these services were being carried CQC inspection, which was carried out in May, also found that the firm was supporting children and younger adults with personal care when it was not registered to do so. Poor leadership Hazel Roberts, the CQC deputy director of operations in the East of England, said: "When we inspected the Hearts of Care Agency, we were concerned to find the service wasn't always meeting people's needs safely, because leaders weren't managing the service well."Leaders had not registered with CQC to care for children, young people, autistic people, or people with a learning disability, but were providing care to them anyways. "We were deeply concerned to find staff didn't always understand how best to support their individual needs or respect their rights." Mark Elvidge, the director of Hearts of Care Agency, said: "Following our recent assessment Hearts of Care Agency are extremely disappointed with our rating of inadequate. "We have happy clients and happy staff and view this rating as harsh and unfair."However, we will not be complacent about our failings. As a director, I take full responsibility, but I can assure our clients, staff, and public we will learn from our mistakes and shortcomings."He said the firm has a plan in place to make improvements before the next inspection in August. Follow Suffolk news on BBC Sounds, Facebook, Instagram and X.

People born between 2000 and 2009 urged to get lifesaving jab
People born between 2000 and 2009 urged to get lifesaving jab

Daily Mirror

time14 minutes ago

  • Daily Mirror

People born between 2000 and 2009 urged to get lifesaving jab

Experts have expressed concern as uptake of the vaccine has declined People born between certain years are being urged to come forward for a 'lifesaving' vaccine. The NHS is appealing to hundreds of thousands of young people who have yet to receive the crucial human papillomavirus (HPV) vaccine. ‌ This jab can protect you against cervical and other forms of cancer. GP surgeries throughout England will be dispatching vaccine invitations to patients born between 2000 and 2009 (meaning they are aged 16 to 25) whose records indicate they missed their HPV vaccination at school. ‌ The vaccine is routinely administered annually to boys and girls in year 8 (aged 12 to 13) to safeguard them from contracting the HPV infection - which is responsible for nearly all cervical cancers and is associated with cancers of the mouth, throat, anus, penis and vagina. If anyone misses the jab, NHS teams conduct school catch-up visits and organise community clinics for home-schooled children. ‌ However, over the past three years alone, more than 418,000 children left school without receiving the HPV vaccination. It's believed there are many others now aged 16 to 25 who were not vaccinated at school. Therefore, NHS leaders aim to reach as many of these individuals as possible. That is in line with plans to eradicate cervical cancer by 2040 as outlined in the recently published 10 Year Health Plan. ‌ The NHS intends to increase uptake among girls to 90 per cent by 2040, whilst also boosting the number of women undergoing cervical screening. During the 2023/24 academic year, vaccination rates for 14 to 15-year-olds reached 76.7 per cent for girls and 71.2 per cent for boys by year 10. There was also a rise in uptake among year 8 pupils compared to the previous year, with 72.9 per cent of girls and 67.7 per cent of boys receiving the vaccine in 2023/24, up from 71.3 per cent and 65.2 per cent respectively for the first dose in 2022/23. Prior to 2023, two doses were necessary. Dr Amanda Doyle, national director of primary care and community services, said: "This vaccine is hugely important in our fight to eradicate cervical cancer but it isn't just for girls and women – it's also vital for boys and men to get vaccinated to protect themselves against cancers of the mouth, throat or genitals, while preventing spreading the HPV infection to sexual partners who could then develop cervical cancer. ‌ "Too many lives are lost to cervical cancer so the hard work of NHS staff across the country in vaccinating and screening as many people as possible will help us to meet our ambition of wiping out this disease. Encouraging progress has been made recently in increasing uptake but we know there is much more to do. "So if you're eligible for a HPV vaccination or are the parent of a child who is eligible, but didn't get the vaccine at school when they had the chance, I would urge you to come forward when your GP contacts you. Only a single dose is required and it could save you or your child's life." ‌ Public Health and Prevention Minister Ashley Dalton added: "The HPV vaccine is our most powerful tool in our fight to eliminate cervical cancer by 2040. But we've got a long way to go. Thousands of young people are still unvaccinated and vulnerable to this disease – which is so easily prevented. "If you missed your vaccination at school, it's not too late. Don't hesitate to make an appointment with your GP. One jab could save your life." The vaccine is also available to people up to the age of 45 with compromised immune systems and men who engage in sexual activity with other men. The most recent HPV vaccine, launched in England in 2021, has demonstrated increased effectiveness. It's projected to decrease instances of women's cancer by 16 per cent and HPV-related fatalities by nine per cent, compared to its predecessor. Research conducted in England indicates that the HPV vaccine prevents 90 per cent of cervical cancer cases. Just last month, the NHS initiated a new 'ping and book' service, sending digital invitations and reminders for cervical screenings via the NHS App.

Medical trial for penis cancer 'gave me two more years'
Medical trial for penis cancer 'gave me two more years'

BBC News

time14 minutes ago

  • BBC News

Medical trial for penis cancer 'gave me two more years'

A man who was the first to take part in a medical trial for penile cancer says it may have extended his life by two years. Eddie Baker, 83, was given immunotherapy alongside the usual treatment of chemotherapy as part of the clinical trial, named treatment was found to have extended the predicted lifespans of more than half of the participants in the study, which was carried out by University Hospitals Bristol and Weston NHS Foundation Baker, from Yate, South Gloucestershire, said: "All I can say is, it is the most wonderful thing that ever happened to me because I know if I hadn't had that, I would not be on this planet to this day." Mr Baker told the BBC his cancer had been caught late because it took over a year for him to come forward with his symptoms. The NHS says symptoms can include bleeding, a rash, a lump or growth, and a change in skin colour."It didn't look very good," Mr Baker said. "The actual swelling got bigger and bigger and then I was trying to get somewhere to get my life sorted out and find out what it was. It was too late."He had to have an amputation and has been left with incurable cancer. Consultant oncologist and chief investigator of the EPIC study, Professor Amit Bahl, said the stigma around such symptoms often leads to late said: "In cancers like these, there is no support system, you can't go out and talk about it because most patients have never heard you can get cancer in the penis. "If you ask ladies, they have heard about cancer in the cervix, in the vagina, but cancer in the penis never gets talked about."The immunotherapy treatment used in the trial is not available on the NHS, but Professor Bahl is applying to the Cancer Drugs Fund to pay for the small number patients who may benefit. Using immunotherapy to treat cancer is still considered by doctors to be a relatively new more than 60 per cent of the patients in the trial, who all had advanced penile cancer, were found to have had a clinical these patients, predicted lifespans increased to 15 months on Bahl said: "Our aim is to improve outcomes in this rare cancer, which has limited treatment options."Penile cancer can be a very aggressive disease, but this study shows we might be able to give men a little more time."Penile cancer is rare, and it usually presents externally first, so when patients are diagnosed, early treatments which can cure the cancer are possible."The trial has proved so successful that Professor Bahl is now planning to start another trial to give immunotherapy at an earlier stage of the disease, in the hope that it will improve cure rates.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store